# UBS - Pre-Mortem Analysis

## Bank Profile
- **Name**: UBS Group AG
- **Headquarters**: Zurich, Switzerland
- **Type**: G-SIB, Universal Bank, Wealth Management
- **Recent Event**: Acquired Credit Suisse (2023)
- **Regulatory Environment**: FINMA, EMIR (via EU operations)

## Prior Probability
**P(Architect) = 35%** (base rate for European Tier 1 banks)

## Pre-Search Failure Modes

### Failure Mode 1: Credit Suisse Legacy Confusion
**Risk**: Credit Suisse had known CDM engagement (Regnosys partnership). Risk of attributing Credit Suisse evidence to UBS without confirming integration post-acquisition.

**Mitigation**: Distinguish pre-acquisition CS evidence from current UBS evidence. Verify if CS CDM capabilities were retained post-merger.

### Failure Mode 2: Swiss Regulatory Context
**Risk**: Swiss banks operate under FINMA, not directly under EMIR. May have less immediate CDM adoption pressure than EU banks.

**Mitigation**: Consider Swiss regulatory context. Check for voluntary CDM adoption or EU subsidiary compliance.

### Failure Mode 3: Wealth Management vs Investment Banking
**Risk**: UBS is primarily a wealth management bank. Derivatives/CDM may be less central than for investment banking-focused peers.

**Mitigation**: Focus on UBS Investment Bank division, not wealth management. Check for CDM in specific business lines.

### Failure Mode 4: Post-Merger Integration Uncertainty
**Risk**: The Credit Suisse acquisition (2023) creates uncertainty about current technology strategy. Evidence from either legacy bank may not reflect current state.

**Mitigation**: Prioritize evidence from 2024 onward. Note integration uncertainty in caveats.

## Key Research Questions

1. **Credit Suisse CDM Legacy**: Did CS have CDM engagement? If so, was it retained post-acquisition?
2. **Current UBS CDM Activity**: Any direct UBS CDM engagement independent of CS?
3. **FINOS Participation**: Is UBS a FINOS member?
4. **Vendor Relationships**: Regnosys or other CDM vendor partnerships?
5. **EMIR Refit Response**: How is UBS addressing EU regulatory reporting requirements?

## Expected Evidence Patterns

### If ARCHITECT:
- Credit Suisse Regnosys partnership retained
- UBS speakers at CDM events
- FINOS membership
- CDM job postings in London/EU offices

### If PRAGMATIST:
- Credit Suisse CDM work discontinued post-merger
- Focus on integration rather than new initiatives
- No current CDM signals
- Traditional vendor relationships

---
*Pre-Mortem Complete*
*Prior: 35% P(Architect)*
